Genentech = $95?

Rumors are swirling that Roche (Ticker: RHHBY.PK) has increased its bid for Genentech (Ticker: DNA) to $95 per share. I was fortunate to load up on more shares of Genentech this morning in the $89 to $90 range. This has turned into a decent arb play and at this point I have to admit that I'll take the $95 per share. I truly believe that Genentech is worth $100+, but you can't win all the time. Roche just stole a great company!